Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by University of Zurich.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00658294
First received: April 8, 2008
Last updated: April 11, 2008
Last verified: April 2008
  Purpose

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles

  • Trial with medicinal product

Condition Intervention Phase
Alveolar Echinococcosis
Other: Stop treatment
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Estimated Enrollment: 30
Study Start Date: January 2008
Estimated Study Completion Date: January 2009
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Study Population

Patients with inoperable alveolar echinococchosis

Criteria

Inclusion criteria:

  • Patients with inoperable alveolar echinococcosis
  • With negative PET-CT
  • EmII/3-10 serology under long-term chemotherapy with benzimidazoles

Exclusion criteria:

  • Positive PET-CT
  • Positive EmII-3-10 Serology
  • No compliance
  • Reduced life expectancy
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00658294

Contacts
Contact: 01 Studienregister MasterAdmins 41-044-255-1111

Locations
Switzerland
University Hospital Zurich Recruiting
Zurich, Switzerland
Contact       Beat.Müllhaupt@usz.ch   
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Beat Müllhaupt 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: Beat Müllhaupt, University Hospital Zurich
ClinicalTrials.gov Identifier: NCT00658294     History of Changes
Other Study ID Numbers: EK-1351
Study First Received: April 8, 2008
Last Updated: April 11, 2008
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Echinococcosis
Echinococcosis, Hepatic
Cestode Infections
Helminthiasis
Parasitic Diseases
Liver Diseases, Parasitic
Liver Diseases
Digestive System Diseases
Benzimidazole
Anthelmintics
Antiparasitic Agents
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on August 01, 2014